US Edition
HHS Halts mRNA Vaccine Development and Cancels 22 BARDA Projects
- Health Secretary Robert F. Kennedy Jr. announced on Tuesday the termination of $500 million in funding for 22 efforts focused on creating vaccines that utilize mRNA methods.
- Kennedy, a longtime vaccine critic, seeks to move the health department away from mRNA vaccines, calling for investment in better solutions without specifying alternatives.
- These projects target respiratory viruses including flu, COVID-19, and H5N1 and involve pharmaceutical leaders like Pfizer and Moderna developing the halted vaccines.
- MRNA vaccines played a significant role in curbing the spread of COVID-19 during the 2020 pandemic, yet the Kennedy administration is now decreasing its support for these vaccines while ongoing vaccination efforts continue.
- The cancellations suggest a significant policy shift in U.S. vaccine development priorities, potentially affecting future efforts to combat respiratory viruses using mRNA technology.
259 Articles
259 Articles
The measure will not only reduce costs; according to the Minister of Health, mRNA technology does not provide sufficient benefits in this area.
Deutsche Welle
CDE NewsUS cancels mRNA vaccine contracts worth $500 million
The US government has decided to halt the funding of 22 projects focused on the development and manufacturing of mRNA-based vaccines that help fight respiratory diseases like COVID-19 and the flu. The decision, announced by Health Secretary Robert F. Kennedy Jr., stemmed from doubts over vaccines' efficacy and marks the latest attempt in a string of efforts that weave vaccine distrust into US health policy. What did Kennedy say about the vaccine…
The US wants to end several projects on mRNA vaccines that work against infections like Corona. The remedies are ineffective, said Kennedy, without providing any evidence.
Department of Health withdrew funds allocated to develop vaccines that are being developed to combat respiratory viruses
BARDA To Terminate “22 mRNA Vaccine Development Investments” – HHS Secretary RFK Jr. Says
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said the Biomedical Advanced Research and Development Authority (BARDA) is “terminating 22 mRNA vaccine development investments.” “We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,” RFK Jr. s…
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
